The sequencing of the human genome held great promise for better disease treatment and a concomitant reduction in animal experiments. Neither promise has been adequately fulfilled
Get full access to this article
View all access options for this article.
References
1.
EvansJ.P., MeslinE.M., MarteauT.M. & CaulfieldT. (2011). Genomics. Deflating the genomic bubble. Science, New York331, 861–862.
2.
MarshallE. (2011). Human genome 10th anniversary. Waiting for the revolution. Science, New York331, 526–529.
3.
Hudson-ShoreM. (2014). Statistics of Scientific Procedures on Living Animals 2013: Experimentation continues to rise – the reliance on genetically-altered animals must be addressed. ATLA42, 261-266.
4.
Ylä-HerttualaS. (2012). Endgame: Glybera finally recommended for approval as the first gene therapy drug in the European Union. Molecular Therapy20, 1831-1832.
5.
LoebK.R. (2000). Significance of multiple mutations in cancer. Carcinogenesis21, 379-385.
6.
FengH., WangX., ZhangZ., TangC., YeH., JonesL., LouF., ZhangD., JiangS., SunH., DongH., ZhangG., LiuZ., DongZ., GuoB., YanH., YanC., WangL., SuZ., LiY., NandakumarV., HuangX.F., ChenS.Y. & LiuD. (2015). Identification of genetic mutations in human lung cancer by targeted sequencing. Cancer Informatics14, 83-93.
7.
YuD. & HungM.C. (2000). Overexpression of ErbB2 in cancer and ErbB2-targeting strategies. Oncogene19, 6115-6121.
8.
PaezJ.G., JänneP.A., LeeJ.C., TracyS., GreulichH., GabrielS., HermanP., KayeF.J., LindemanN., BoggonT.J., NaokiK., SasakiH., FujiiY., EckM.J., SellersW.R., JohnsonB.E. & MeyersonM. (2004). EGFR mutations in lung cancer: Correlation with clinical response to gefitinib therapy. Science, New York304, 1497-1500.
CombesR.D. & BallsM. (2014). Every silver lining has a cloud: The scientific and animal welfare issues surrounding a new approach to the production of transgenic animals. ATLA42, 137-145.
14.
HendriksenC. & SpielmannH. (2014). New techniques for producing transgenic animals – a mixed blessing from both the scientific and animal welfare perspectives. ATLA42, 93-94.
15.
ButcherE.C., BergE.L. & KunkelE.J. (2004). Systems biology in drug discovery. Nature Biotechnology22, 1253-1259.
